Announced Tue, 25 Aug, 2026 · 20:39 IST
CRISIL reaffirms ratings; outlook revised to Positive
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹22954.00
prior close
₹23070.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.5+0.5+1.5+2.0+0.9+0.1+0.4+0.0-1.5-1.5-6.6——
Up moveDown movePending
AI summary
CRISIL has reaffirmed Neuland Lab's long-term rating at A+ and revised the outlook to Positive. The short-term rating of A1 has also been reaffirmed. A Positive outlook indicates CRISIL may upgrade the rating in the next 12 to 18 months if current financial trends continue, signaling improving credit profile and operational strength.
Likely market impact
Positive for shareholders; outlook upgrade may boost investor confidence and support lower future borrowing costs.